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Thrombospondin (TSP) is a 450-kDa glycoprotem synthesized and secreted by human MG-63 osteoblastic cells. In this study, we have first studted 
the effect of a-thrombin on TSP expression by human MG-63 cells. In situ hybridization indicated that TSP mRNA level in thrombm-treated MG-63 
cells was increased when compared to unsttmulated cells. As judged by tmmunofluorescence, thrombin-treatment of MG-63 cells resulted in 
increased cell surface expression of TSP when compared to quiescent cells. Because thrombin stimulates proliferation of osteoblastic cells, the 
mvolvement of TSP in proliferation of thrombin-stimulated osteoblasttc cells was then investigated using a serum-free mitogenesis assay. Both 
a-thrombin (0.01 to 0.15 U/ml) and TSP (5 to 600 @ml) caused a dose-dependent increase in [jH]thymidine incorporation by MG-63 cells. 
Proliferation of osteoblastic cells induced by a-thrombin or TSP was specifically and totally inhibited by anti-TSP monoclonal antibodies (3-10 
&ml) or by mdomethacm (1 PM), an inhibitor of prostaglandm synthesis. Anti-TSP antibodies which inhibited cell proliferation also inhibit TSP 
expression to the surface of these cells. Our experiments support the existence of a mechamsm whereby TSP bound to the cell surface of 
thrombm-treated MG-63 cells stimulates secretion of prostaglandms which, in turn, allow cell proliferation to proceed. 
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1. INTRODUCTION 
Thrombospondin (TSP) is a trimeric extracellular 
matrix glycoprotein of 450 kDa synthesized and se- 
creted by a wide range of normal and transformed cells 
[ 11. Recently, five distinct genes encoding for four struc- 
turally different TSPs (TSPl, TSP2, TSP3, and TSP4). 
and cartilage oligomeric matrix protein (COMP) have 
been described [2]. The functions of TSP2, TSP3, TSP4, 
and COMP are unknown. TSPl has been described as 
a protein that modulates cellular proliferation. In situ. 
there is a precise regional and temporal appearance of 
TSP during organogenesis of mouse embryo. followed 
by a disappearance as differentiation proceeds [3]. In 
vitro, quiescent smooth muscle cells stimulated with 
platelet-derived growth factor (PDGF) rapidly secrete 
and elaborate a TSP-rich extracellular matrix which, in 
turn, facilitate growth of smooth muscle cells in re- 
sponse to EGF [4,5]. TSP also promotes proliferation 
of fibroblasts [6]. 
mineralized bone matrix of neonatal and young (grow- 
ing) bone of many animal species [S]. However, the 
significance of TSP in bone tissue is not known. The 
serine protease thrombin, best known for its central role 
in hemostasis, is emerging as a potent activator of both 
cell adhesion and proliferation [9], and has been shown 
to stimulate proliferation of human G292 and Saos-2 
osteoblastic cells [ 10.1 11. These findings, taken together 
with the fact that TSP stimulates the growth of fibro- 
blasts and smooth muscle cells [4-61, prompted us to 
examine whether it is involved in the proliferation of 
human osteoblastic cells induced by thrombin. 
2. MATERIALS AND METHODS 
We have previously reported that human MG-63 and 
Saos-2 osteoblastic cells in culture synthesize and se- 
crete TSP [7]. In addition, TSP has been identified in the 
EcoRI, [‘Hlthymtdine and [a-‘?j]UTP were purchased from Amer- 
sham Proteinase K was from Boehrmger. Human a-thrombin was 
from Fibrindex (Ortho Diagnostic Systems). PPACK was purchased 
from Calbtochem. Human platelet TSPl was obtained from Stago 
(France) or was purified as previously described [I 21. Mouse monoclo- 
nal antibodies PlO and MA-II are directed at distmct epitopes of 
human blood platelet TSPl. The characterization and specificity of 
these antibodies have been described earlier [13.14]. Mouse monoclo- 
nal antibody MARK 1 directed against rat IC light chains was pur- 
chased from Immunotech (France). 
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Human osteosarcoma cell hne designated MG 63 was obtained 
from the American Type Culture Collection (Rockville, MD). MG 63 
cells were cultured in RPM1 1640 medium containing 10% (v/v) fetal 
calf serum. 
Human cDNA clone M9 specific for TSPl was kindly provided by 
Dr. Jack Lawler (Boston. MA) [15]. The cDNA was inserted into the 
EcoRI site of pGEM-2 (Promega Biotec) and used to derived antt- 
sense and sense probes. RNA probes were generated using 100 /Zi 
[a-‘“SIUTP, and either SP6 or T7 polymerases as previously described 
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[16]. For m sttu hybridizatton, cells resuspended m RPM1 medium 
contaming 10% (v/v) fetal calf serum were plated at a density of 3,000 
cells per cm’ in glass chamber shdes (Lab Tee) and allowed to attach 
overnight m a 5% CO? incubator at 37°C. After incubation, cells were 
washed and cultured m RPM1 medium contaming 1% (m/v) BSA for 
24 h. Cells were then stimulated with a-thrombin (0 1 U/ml) for 48 h. 
After washing, cells were fixed in 2% (m/v) paraformaldehyde (in PBS) 
for 15 min. washed twice m PBS, dehydrated by immersion in ethyl 
alcohol. and an-dried. Cells were then pretreated for 5 min with PBS 
containing 5 mM MgCL, then incubated for 8 mm with 5 izg/ml 
protemase K (in PBS). rmsed twice in PBS and dehydrated m ethyl 
alcohol. hybridization with the RNA probes. and the subsequent 
steps of the procedure have been detailed previously [16] 
For cell proliferation. MC-63 cells resuspended in RPM1 medium 
containing 10% (v/v) fetal calf serum were plated at a density of 13.000 
cells/cmz m 96.well flat-bottom culture dishes. After 24 h incubation 
in a 5% CO, mcubator at 37OC, cells were washed and cultured m 
RPM1 medium containmg 1% (m/v) BSA to made ceils qutescent 
After 24 h mcubation. quiescent cells were stimulated for 48 h wrth 
increasing concentrations of a-thrombm (0 01 to 0 15 U/ml) m the 
presence or absence of PPACK (1 FM). Alternatively, mcreasmg con- 
centrations of TSP (5 to 600 rig/ml) instead of a-thrombm were added 
to quiescent MG-63 cells. Inhibition studies were conducted m the 
presence of a-thrombin (0. I U/ml) and increasing concentrations (3 
to IO &ml) of either antt-TSP mouse monoclonal antibody PI0 or 
negative control mouse monoclonal antibody MARK I. During the 
last 12 h of the 48-h mcubation period, cells here pulsed with 1 @CI 
of [‘W]thymidine/well. At the end of the incubation, cells were washed 
three times with PBS and harvested after brief exposure to trypsin (0.5 
mg/ml) and EDTA (0.5 mM). Trypsm/EDTA-treated cells were then 
resuspended and counted. Results obtained for each concentration of 
thrombin. TSP or antibody were the mean + S.D. of quadriphcate 
dete~lnations. 
For immunofluorescence. cells resuspended m RPM1 medium con- 
taming 10% (v/v) fetal calf serum were plated at a density of 3.000 cells 
per cm’ m glass chamber slides. and allowed to attach and spread for 
24 h m a 5% CO, Incubator at 37°C. After mcubation, cells were 
washed and cultured m RPM1 medium containing 1% (m/v) BSA for 
24 h. Quiescent cultured cells were left untreated or were exposed to 
~-thrombin (0.1 U/ml) m the presence ofetther anti-TSP antibody PI0 
or negative control antibody MARK-l (5 ~&If. After 48 h mcuba- 
tion at 37°C. cells were washed m PBS and fixed for 1 h at 4°C in 4% 
formaldehyde, After washing. cells were exposed to a rabbit polyclo- 
nal anti-TSP antibody (0.1 pg/ml) for overnight at 4°C. FITC-labeled 
secondary antibody (goat anti-rabbit antibody) was used at a l/50 
dilution and was incubated for 90 mm at room temperature Cells were 
photographed on a Zetss Axioplan microscope 
3. RESULTS 
3. I. In situ hybridizution 
With the specific antisense probe, there was high- 
intensity hybridization over quiescent MG-63 osteob- 
lastic cells. while only minimal hybridization was ob- 
served with the sense probe (Fig. lA,B). Stimulation of 
MG-63 cells with ol-thrombin (0.1 U/ml) caused a dras- 
tic increase in TSPI mRNA expression (as judged by 
grain densities) (Fig. IC) when compared to unstimu- 
lated cells (Fig. 1A). Nonspecific hybridization for 
thrombin-stimulated cells (Fig. 1D) was to a level simi- 
lar to that observed for their unstimulated counterparts 
(Fig. 1B). 
3.2. ~rnrn~~o~~io~escence 
Untreated and ~-thrombin-treated MC-63 cells incu- 
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bated with anti-TSP monoclonal antibody PI0 or nega- 
tive control monoclonal antibody M.L\RK-I were exam- 
ined by immullofluorescence after formaldehyde fixa- 
tion and staining with an anti-TSP polyclonal antibody. 
Under these conditions. cell membranes are not affected 
and the staining reflects only cell surface expression of 
TSP. As shown in Fig. 2. immunostaining of quiescent 
MG-63 cells revealed a uniform distribution of TSP 
over the cell surface. After ~-thrombin-treatment in the 
presence of antibody MARK- 1, cells became round and 
a strong cell surface staining was observed for TSP (Fig. 
2). By contrast, the use of anti-TSP antibody PI0 in- 
stead of antibody MARK-l, markedly decreased cell 
surface expression of TSP (Fig. 2). The use of a-throm- 
bin in the presence of PPACK reduced cell surface ex- 
pression of TSP to a level similar to that found with 
quiescent MG-63 cells. No immunofluorescence was 
observed when a non-immune antibody was used in- 
stead of the anti-TSP polyclonal antibody. 
It has been recently shown that thrombin stimulates 
proliferation of human G292 and Saos-2 osteoblastic 
cells [IO,1 11. Experiments conducted with human MG- 
63 osteoblastic cells showed that cl-thrombin caused a 
significant, dose-dependent increase in [‘Hlthymidine 
incorporation by these cells, reaching a plateau at con- 
centrations ranged from 0.1 to 0.15 U/ml (Fig. 3A). The 
effect of a-thrombin on MG-63 cells was abolished in 
the presence of PPACK (1 PM). a synthetic peptide 
which specifically inhibits thrombin activity, Increasing 
concentrations of TSP ranged from 5 to 600 ng/ml also 
caused a significant, dose-dependent increase in 
[3H]thymidine incorporation by MG-63 cells when com- 
pared to untreated cells (Fig. 3B). The maximum effect 
was seen at a TSP concentration of 500 ng/ml. Addition 
of anti-TSP antibody PI0 (5 pug/ml) to TSP (500 ng/ml) 
markedly reduced [3H]thymidine incorporation from 
760 * 129% to 109 + 21% of untreated cells. 
Because ol-thrombin stimulates TSP expression and 
proliferation of human MG-63 osteoblastic cells, MG- 
63 cells were therefore stimulated wit a-thrombin (0.1 
U/ml) in the presence of increasing concentrations (3 
and IO yglml) of either anti-TSP antibody PlO or nega- 
tive control antibody MARK-l (Fig. 4). MARK 1 only 
exhibited slight inhibition of [‘Hjthymidine incorpora- 
tion by thrombin-stimulated cells (Fig. 4B.C). By con- 
trast, PI0 drastically reduced [3H]thymidine incorpora- 
tion by thrombin-stimulated cells from 777 & 14% to 
51 F 1% of the control (Fig. 4D.E). Similar results were 
obtained with anti-TSP monoclonal antibody MA-II. 
Reduction in [3H]thymidine incorporation by MG-63 
cells observed with PlO and MA-II did not result of cell 
detachment by these antibodies, since direct cell count- 
ing failed to show any significant loss in cell number as 
a result of antibody treatment. The effect of indometha- 
tin (a specific cyclooxygenase inhibitor) on prolifera- 
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Fig. 1. Localization of TSPl mRNA in human MG-63 osteoblastic by in situ hybridization. (A) Darkfield photomicrograph of quiescent Mf 
cells hybridized with an anttsense probe. Note the specific localization of silver grains over MG-63 cells when compared to the sense probe 
(C) Darkfield photomicrograph of thrombin-treated MG-63 cells with an antisense probe. A higher grain density is observed over thron 
stimulated cells when compared to quiescent cells. (D) Nonspecific hybridization of thrombin-treated cells with a sense probe. 
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Fig. 3. (A) Effect of increasing concentrations of &-thrombm on prohferatton of human MG-63 osteoblastic ells. Data were obtained as cpm 
[Whhymidine incorporated by thrombin-stimulated cells and normalized as a percentage ofthe mean cpm incorporated by untreated cells. Negative 
control experiments were conducted with thrombin in the presence of PPACK. Results are the mean t SD. of quadriplicate determinations. Five 
independent expertments were carried out with similar results. (B) Effect of increasing concentrattons of TSP on proliferation of human MG-63 
cells. Results were expressed as described above. Four independent experiments were carried out with similar results. 
tion of human MG-63 cells was also studied (Fig. 5). In 
the presence of indomethacin (1 PM) and TSP (500 
ng/ml), [“Hlthymidine incorporation by MG-63 cells is 
only 242 t 8% of the control value, while TSP alone 
induced a 760 2 129% increase incorporation when 
compared to quiescent cells. Similarly, a-thrombin (0.1 
U/ml) in conjunction with indomethacin (1 PM) re- 
duced [3H]thymidine incorporation by MG-63 cells to 
78.3 + 18.2% of the control value, while ol-thrombin 
alone induced a 862 rt 150% increase in [3H]thymidine 
incorporation by MC-63 ceils when compared to un- 
treated cells. [3H]Thymidine incorporation by MG-63 
cells in the presence of indomethacin (1 PM) alone was 
84.4 Zt 6.7% of the control value. 
4. DISCUSSION 
We previously observed that human MG-63 osteo- 
blastic cells synthesize, secrete and bind TSP in a recep- 
tor-like fashion [7,17]. The present study shows that, in 
vitro, TSP mediates proliferation of human MC-63 os- 
teoblastic cells induced by a-thrombin. The observation 
that TSP mediates proliferation of MG-63 cells is based 
on a number of findings: (a) a-thrombin concomitantly 
stimulates TSP expression and proliferation of osteo- 
blastic cells, and proliferation of thrombin-stimulated 
cells is specifically inhibited by anti-TSP monoclonal 
antibodies PI0 and MA-II; (b) TSP itself induces prolif- 
eration of MC-63 cells; and (c) this proliferative effect 
of TSP is specifically inhibited by anti-TSP antibody 
PlO. The growth supportive effects of a-thrombin and 
TSP are similar with respect o [3H]thymidine incorpo- 
ration (862 +_ 150% and 760 z!z 129% increase of the con- 
trol, respectively). The mechanisms by which ol-throm- 
bin and TSP stimulate cell growth are not known. 
Mouse osteoblasts and MC3T3-El osteoblastic ells re- 
t 
Fig. 2. Immunofluorescence localization of TSP to the surface of human MG-63 osteoblastic ells. Untreated ceils (control) and thrombin-treated 
cells incubated with anti-TSP monoclonai antibody PI0 or negative control monoclonal anttbody MARK-l were examined after formaldehyde 
fixation and staming with an anti-TSP polycfonal antibody. The experiment was carried out two times with similar results. 
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Fig. 4. Effect of arm-TSP monoclonal antibody PI0 on proliferatton Ftg. 5 Effect of indomethacm (1 PM) (1.m.f on proliferation of human 
of human MG-63 osteoblastic cells induced by a-thrombm (0.1 U/ml). MG-63 osteoblastrc cells induced by TSP (500 t&ml) or a-thrombin 
Negative control monoclonal anttbody MARK I IS isotype-matched (0.1 U/ml). Results were expressed as described m the legend of Fig. 
wtth PlO. Results were expressed as descrtbed in the legend of Ftg. 3. 3. Three independent expertments were carrted with simtlar results. 
Three Independent experiments were carried out wtth similar results 
spond to thrombin with rapidly enhanced formation of 
prostaglandins such as PGEz [ 181, and PGE, stimulates 
proliferation of osteoblastic cells in vitro and bone for- 
mation in vivo [19]. We have shown in this study that 
indomethacin, which is known to inhibit prostaglandin 
synthesis 119). inhibits the effects of both ff-thrombin 
and TSP on proliferation of MG-63 cells. In this re- 
spect, our data strongly suggest that the growth-suppor- 
tive effects of cr-thrombin and TSP on MG-63 cells are 
mediated by prostaglandins. Moreover. cell surface-as- 
sociated TSP appears functionally essential for the pro- 
liferation of human MG-63 osteoblastic cells because 
anti-TSP monoclonal antibody PlO which inhibits pro- 
liferation of thrombin-stimulated osteoblastic cells also 
inhibits TSP expression on the surface of these cells. 
Similarly, anti-TSP antibodies drastically inhibit both 
proliferation of rat aortic smooth muscle cells and cell 
surface expression of TSP [5]. Taken together, our ex- 
periments support the existence of a mechanism 
whereby TSP bound to the cell surface of thrombin- 
stimulated MG-63 cells stimulates secretion of prosta- 
glandins which, in turn, allow cell proliferation to pro- 
ceed. 
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